Russia Develops Groundbreaking mRNA Cancer Vaccine Worth Rs 2.47 Crore; To Distribute For Free
Russia has developed a personalised mRNA cancer vaccine, launching in 2025, using patient tumor material. Distributed free, it costs 300,000 rubles per dose. The vaccine trains immunity to target cancer cells. With 635,000 cancer cases reported in 2022, it mirrors US and UK efforts in personalised treatment trials.
.
.
.
#cancertreatment #mrnavaccine #personalisedmedicine #cancerresearch #medicalbreakthrough #russiahealth #cancerimmunotherapy #tumorvaccine #oncologyadvancements #globalhealth #cancercare #medicaltechnology #mirrornow #mirrornoworiginalsSUBSCRIBE NOW | https://bit.ly/SubscribeToMirrorNow
For More Updates ► http://www.mirrornownews.com
Like us on Facebook ► https://www.facebook.com/MirrorNow
Follow us on Twitter ► https://twitter.com/MirrorNow
Follow us on Instagram ► https://www.instagram.com/mirrornow_in/
Subscribe to our other network channels:
Times Now Navbharat: https://bit.ly/SubscribeToTNNavbharat
Zoom: https://bit.ly/SubscribeToZoom
Times Now: https://bit.ly/SubscribeToTimesNow
ET Now: https://bit.ly/SubscribeToETNow
TN+: https://bit.ly/SubscribeToTNPlus
